Innovation
5 patent families (5 granted) — focus: Human necessities; filing pace dormant. Cited 318 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
Investor mix
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |
Developer of re-purpose molecules for the treatment of coma recovery, sialorrhea and premature ejaculation
5 patent families (5 granted) — focus: Human necessities; filing pace dormant. Cited 318 times.
| Year | Filings |
|---|---|
| 2012 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
1 investor on record.
| Investor type | Count | Share |
|---|---|---|
| Other / undisclosed | 1 | 100% |